Company Overview of Marinus Pharmaceuticals, Inc.
Key Executives for Marinus Pharmaceuticals, Inc.
|Christopher Michael Cashman||65 Relationships||Executive Chairman, Chief Executive Officer and President||59|
|Edward F. Smith||No Relationships||Chief Financial Officer, Vice President, Treasurer and Secretary||45|
|Kimberly A. McCormick PharmD||No Relationships||Head of Regulatory Affairs||--|
|Albena Patroneva M.D.||No Relationships||Chief Medical Officer||51|
Marinus Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Christopher Michael Cashman||65 Relationships||Marinus Pharmaceuticals, Inc.||59|
|Nicole Vitullo M.B.A.||52 Relationships||Domain Associates, L.L.C.||59|
|Timothy M. Mayleben||60 Relationships||Esperion Therapeutics, Inc.||55|
|Jay P. Shepard||36 Relationships||Versartis, Inc.||58|
|Enrique J. Carrazana M.D.||5 Relationships||Acorda Therapeutics, Inc.||54|
Marinus Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Timothy M. Mayleben||60 Relationships||3 Executives|
|Compensation Committee||Jay P. Shepard||36 Relationships||2 Executives|
|Nominating Committee M.B.A.||Nicole Vitullo||52 Relationships||3 Executives|
|Corporate Governance Committee M.B.A.||Nicole Vitullo||52 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$651.8K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.